CXCL12 deficiency promotes colorectal cancer progression and reduces anti-PD-L1 immunotherapy efficacy through MDSC regulationHeping Zhao, Xing Chen, Yuhan Wang et al.|Journal of Translational Medicine|2025Cited by 1